FDA recall D-0541-2023
Wellness BioSciences · Class II · drug
Product
CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered Sprays, Wellness BioSciences Rx
Reason for recall
Marketed Without an Approved NDA/ANDA
Distribution
Nationwide within the United States
Key facts
- Status
- Ongoing
- Initiation date
- 2022-04-01
- Report date
- 2023-05-03
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Houston, TX, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0541-2023